Eco Animal Health Group PLC Posting of the Annual Report and Notice of AGM
August 16 2024 - 1:00AM
RNS Regulatory News
RNS Number : 6644A
Eco Animal Health Group PLC
16 August 2024
16 August
2024
ECO Animal Health Group
plc
("ECO" or
the "Company")
Posting of the Annual Report and Notice
of AGM
ECO Animal Health Group plc (AIM: EAH), a
rapidly growing global animal health company with a portfolio of
marketed veterinary products and a maturing proprietary R&D
pipeline, announces that its Annual Report and Accounts for the
year ended 31 March 2024 and Notice of Annual General Meeting
("AGM") together with Form of Proxy have today been sent to
shareholders who have elected to receive hard copies by
post.
The Annual Report and Accounts is available on
the Company's website at https://ecoanimalhealth.com/investors/.
The Company will hold its AGM at The Grange,
100 High Street, London, N14 6BN on Thursday, 26 September 2024 at
9:00 am.
A copy of the Notice of AGM and Form of Proxy
will be available on the Company's website at https://ecoanimalhealth.com/investors/.
-Ends-
For further
information please contact:
|
ECO Animal
Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO)
|
020 8447 8899
|
|
Singer Capital
Markets (Nominated Adviser & Joint Broker)
Phil Davies
Sam Butcher
|
020 7496 3000
|
|
Investec
(Joint Broker)
Gary Clarence
Lydia Zychowska
|
020 7597 5970
|
|
Equity
Development
Hannah Crowe
Matt Evans
|
020 7065 2692
|
|
ICR Consilium
(Financial PR)
Mary-Jane Elliott
Jessica Hodgson
|
020 3709 5700
ecoanimalhealth@consilium-comms.com
|
|
|
About ECO
Animal Health
ECO Animal Health is a world leader in animal
health, developing and marketing branded veterinary pharmaceuticals
globally, with expertise in antibiotics and vaccines for pigs and
poultry. We have a maturing proprietary R&D
pipeline.
Headquartered in the UK, with global offices
including R&D and manufacturing, we have marketing
authorisations in over 70 countries and employ over 200 people
worldwide.
Our lead product, Aivlosin® is a proprietary,
patented medication which is effective against both respiratory and
intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
ACSMZGMRVKVGDZM
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Nov 2024 to Dec 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Dec 2023 to Dec 2024
